On Cytokines, Fluvoxamine and COVID-19

Early in the COVID-19 pandemic, the role of ‘cytokine storm’ in patients with severe course was raised. Indeed, this triggered multiple investigations centred around calming excessive inflammation with pharmacotherapies... read more

On Cytokines, Fluvoxamine and COVID-19

Inflammatory Response and Phenotyping in SARI From the MERS Coronavirus

One third of critically ill patients with Middle East respiratory syndrome (MERS) severe acute respiratory infection (SARI) and non-Middle East respiratory syndrome severe acute respiratory infection demonstrated a subphenotype... read more

Inflammatory Response and Phenotyping in SARI From the MERS Coronavirus

Why COVID-19 Pneumonia is More Deadly than Typical Pneumonia

Bacteria or viruses like influenza that cause pneumonia can spread across large regions of the lung within hours. In the modern intensive care unit, these bacteria or viruses are usually controlled either by antibiotics or... read more

Why COVID-19 Pneumonia is More Deadly than Typical Pneumonia

Impaired peripheral mononuclear cell metabolism in patients at risk of developing sepsis

Dysregulated immune response is a key driver of disease progression in sepsis and known to be associated with impaired cellular metabolism. This association has been studied mostly in the late stage sepsis patients. Here,... read more

Impaired peripheral mononuclear cell metabolism in patients at risk of developing sepsis

Longitudinal Analyses Reveal Immunological Misfiring in Severe COVID-19

Recent studies have provided insights into the pathogenesis of COVID-19. Yet, longitudinal immunological correlates of disease outcome remain unclear. Here, we serially analysed immune responses in 113 COVID-19 patients with... read more

Longitudinal Analyses Reveal Immunological Misfiring in Severe COVID-19

Corticosteroids for Critically Ill COVID-19 Patients with Cytokine Release Syndrome

Approximately 5% of coronavirus disease (COVID-19) patients will require admission to an intensive care unit (ICU). Among these patients, the most severe cases may be mediated by a late-onset systemic inflammatory response... read more

Corticosteroids for Critically Ill COVID-19 Patients with Cytokine Release Syndrome

The Protective Effects of Regional Hypothermia on Injured Limbs Combined with Hemorrhagic-shock & Tourniquet

The aim of this study is to investigate the protective effects of regional hypothermia (RH) on rabbits' limbs injured by a steel-ball combined with hemorrhagic-shock, and then employed tourniquet over-time, tried to identify... read more

The Protective Effects of Regional Hypothermia on Injured Limbs Combined with Hemorrhagic-shock & Tourniquet

New Cytokine Approach is Synergistic With Checkpoint Inhibitors

Among the new agents currently being explored in clinical trials, NKTR-214 stands out as a new cytokine therapy approach that could show additive benefit when combined with checkpoint inhibitors. ... read more

New Cytokine Approach is Synergistic With Checkpoint Inhibitors